fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

Vasil Kisil & Partners successfully represented the Lekhim Group of Pharmaceutical Companies in a commercial dispute over the fulfilment of a vaccine supply agreement for almost UAH 1 Billion

15/ 05/ 2024
  Attorneys from Vasil Kisil & Partners successfully represented Lekhim Joint Stock Company, one of Ukraines leading pharmaceutical companies engaged in the development, manufacture, and sale of medicinal products, in a commercial dispute with the Medical Procurement of Ukraine State Enterprise. The dispute between Lekhim and Medical Procurement of Ukraine arose from the fulfillment of a supply agreement for more than 1.9 million doses of the SARS-CoV-2 CoronaVac vaccine manufactured by Sinovac Biotech Ltd, a China-based biopharmaceutical company. Lekhim and Medical Procurement of Ukraine entered into the vaccine supply agreement in December 2020 at the initiative of the Ministry of Health of Ukraine for almost UAH 1 billion. This was the first agreement in Ukraine for the supply of a COVID-19 vaccine, with the supply taking place in the first half of 2021. Medical Procurement of Ukraine filed a claim against Lekhim in a commercial court seeking the recovery of fines and penalties totaling almost UAH 70 million, alleging that Lekhim failed to observe the vaccine delivery period. The claimant insisted that Lekhim had delayed the delivery of the first and second shipments of the CoronaVac vaccine. In response, Lekhim denied any delay in delivery. After reviewing the case, the commercial courts upheld the respondent’s (Lekhim’s) position by 97%, meaning that less than 3% of the claimed penalties were ordered to be paid.  The team of attorneys from Vasil Kisil & Partners who represented Lekhim Joint Stock Company included Andriy Stelmashchuk, Managing Partner and Attorney-at-Law, Yurii Kolos, Counsel and Attorney-at-Law, and Hanna Rud, Senior Associate and Attorney-at-Law. ### For more details please contact Olga Shevchenko, PR Manager Tel.: +380 67 358 47 82 E-mail: [email protected] About the Firm Established in 1992, Vasil Kisil & Partners is a Ukrainian law firm that delivers integrated legal advice in banking & finance, mergers & acquisitions, capital markets, antitrust, competition and trade, dispute resolution, public advocacy, tax law, energy and natural resources law, intellectual property law, labor and employment law, real estate and construction law, as well as PPP, concessions and infrastructure law. Vasil Kisil & Partners is a member and exclusively represents Ukraine in such international professional associations as TerraLex (160 law firms in 100 countries), Cathay Associates (40 high-profile law firms with over 500 headcount worldwide in 43 major cities and countries across Europe and Asia) and Ius Laboris (1700 labor and employment lawyers in 50 countries). Andriy Stelmashchuk is a managing partner of Vasil Kisil & Partners law firm.

Attorneys from Vasil Kisil & Partners successfully represented Lekhim Joint Stock Company, one of Ukraine’s leading pharmaceutical companies engaged in the development, manufacture, and sale of medicinal products, in a commercial dispute with the Medical Procurement of Ukraine State Enterprise.

The dispute between Lekhim and Medical Procurement of Ukraine arose from the fulfillment of a supply agreement for more than 1.9 million doses of the SARS-CoV-2 CoronaVac vaccine manufactured by Sinovac Biotech Ltd, a China-based biopharmaceutical company.

Lekhim and Medical Procurement of Ukraine entered into the vaccine supply agreement in December 2020 at the initiative of the Ministry of Health of Ukraine for almost UAH 1 billion. This was the first agreement in Ukraine for the supply of a COVID-19 vaccine, with the supply taking place in the first half of 2021.

Medical Procurement of Ukraine filed a claim against Lekhim in a commercial court seeking the recovery of fines and penalties totaling almost UAH 70 million, alleging that Lekhim failed to observe the vaccine delivery period.

The claimant insisted that Lekhim had delayed the delivery of the first and second shipments of the CoronaVac vaccine. In response, Lekhim denied any delay in delivery.

After reviewing the case, the commercial courts upheld the respondent’s (Lekhim’s) position by 97%, meaning that less than 3% of the claimed penalties were ordered to be paid. 

The team of attorneys from Vasil Kisil & Partners who represented Lekhim Joint Stock Company included Andriy Stelmashchuk, Managing Partner and Attorney-at-Law, Yurii Kolos, Counsel and Attorney-at-Law, and Hanna Rud, Senior Associate and Attorney-at-Law.

###

For more details please contact Olga Shevchenko, PR Manager
Tel.: +380 67 358 47 82

E-mail: [email protected]

About the Firm

Established in 1992, Vasil Kisil & Partners is a Ukrainian law firm that delivers integrated legal advice in banking & finance, mergers & acquisitions, capital markets, antitrust, competition and trade, dispute resolution, public advocacy, tax law, energy and natural resources law, intellectual property law, labor and employment law, real estate and construction law, as well as PPP, concessions and infrastructure law. Vasil Kisil & Partners is a member and exclusively represents Ukraine in such international professional associations as TerraLex (160 law firms in 100 countries), Cathay Associates (40 high-profile law firms with over 500 headcount worldwide in 43 major cities and countries across Europe and Asia) and Ius Laboris (1700 labor and employment lawyers in 50 countries). Andriy Stelmashchuk is a managing partner of Vasil Kisil & Partners law firm.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Start
in the Telegram bot
Read articles. Share in social networks

Spelling error report

The following text will be sent to our editors: